ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23)

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 2, 2009, Pages 172-177

  Zhang, Da ^a   Denley, Ryan C ^a   Filippa, Daniel A ^a   Teruya Feldstein, Julie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ALK; Clathrin; DLBCL; NPM; Plasmablastic; t(2; 5); t(2; 7)(p23; q23)

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD20 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; IMMUNOGLOBULIN A; PREDNISONE; PROTEIN P63; SYNDECAN 1; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVIN RECEPTORS, TYPE II; ADULT; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 2; DIAGNOSIS, DIFFERENTIAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; TRANSLOCATION, GENETIC;

EID: 67849128268     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31818629a8     Document Type: Article

References (22)

1. Chiarle R, Voena C, Ambrogio C, et al. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008;8:11-23.
2. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561-566. (Pubitemid 47206930)
3. Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood. 1997;89:1483-1490. (Pubitemid 27097438)
4. Touriol C, Greenland C, Lamant L, et al. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood. 2000;95:3204-3207. (Pubitemid 30321174)
5. Gascoyne RD, Lamant L, Martin-Subero JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood. 2003;102:2568-2573. (Pubitemid 37193597)
6. Chikatsu N, Kojima H, Suzukawa K, et al. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol. 2003;16:828-832.
7. De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood. 2003;102:2638-2641. (Pubitemid 37193606)
8. McManus DT, Catherwood MA, Carey PD, et al. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol. 2004;35:1285-1288.
9. Reichard KK, McKenna RW, Kroft SH. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Mod Pathol. 2007;20:310-319. (Pubitemid 46348332)
10. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel: Karger; 1995.
11. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747. (Pubitemid 38685887)
12. Ishii K, Yamamoto Y, Nomura S. CD30-negative diffuse large B-cell lymphoma expressing ALK. Rinsho Ketsueki. 2005;46:501-506.
13. Gesk S, Gascoyne RD, Schnitzer B, et al. ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas. Leukemia. 2005;19:1839-1840. (Pubitemid 41486165)
14. Rudzki Z, Rucinska M, Jurczak W, et al. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review. Pol J Pathol. 2005;56:37-45. (Pubitemid 40732870)
15. Bubala H, Maldyk J, Wlodarska I, et al. ALK-positive diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2006;46:649-653.
16. Isimbaldi G, Bandiera L, d'Amore ES, et al. ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement. Pediatr Blood Cancer. 2006;46:390-391. (Pubitemid 43201862)
17. Wang WY, Ma ZG, Li GD, et al. Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases. Zhonghua Bing Li Xue Za Zhi. 2006;35:529-534.
18. Stachurski D, Miron PM, Al-Homsi S, et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 30 ALK gene insertion to chromosome 4 q22-24. Hum Pathol. 2007;38:940-945. (Pubitemid 46726518)
19. Lee HW, Kim K, Kim W, et al. ALK-positive diffuse large B-cell lymphoma: report of three cases. Hematol Oncol. 2008;26:108-113. (Pubitemid 351951340)
20. Choung HS, Kim HJ, Kim WS, et al. Cytomorphology and Molecular Characterization of CLTC-ALK Rearrangement in 2 Cases of ALK-Positive Diffuse Large B-cell Lymphoma with Extensive Bone Marrow Involvement. Korean J Lab Med. 2008;28:89-94.
21. Adam P, Katzenberger T, Seeberger H, et al. A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation. Am J Surg Pathol. 2003;27:1473-1476. (Pubitemid 37315202)
22. Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood. 2003;102:2642-2644. (Pubitemid 37193607)